RxDoctor Payments Data

Rachel Perl, DPM

Foot & Ankle Surgery · Middletown, NYNPI 1043555352

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 63.9% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $695, 6.7 times the $103 reported in 2019. That places this record below the midpoint for foot & ankle surgery clinicians in NY, where the typical reported total is $2,113.

$1,154in general payments, 2019–2025

Across 32 payments — averaging $36.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$738
  • Treace Medical Concepts, Inc.$180
  • Zimmer Biomet$96
  • Stryker$36
  • Medtronic$22
  • Sandoz$22
  • plus $60 from 3 others

What the payments were for

  • Food & beverage$1,154100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,154 in reported general payments places this provider in the 35th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York →

Medicare billing

Part B allowed, 2024
$134,802
Medicare patients
441
Services billed
1,554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox68$2,259
Ketoconazole66$2,140
Ammonium Lactate114$1,975
CiclopiroxCiclopirox Olamine72$1,970
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip56$1,805
Terbinafine Hcl58$432
Methylprednisolone47$364
Diclofenac Sodium14$287
SsdSilver Sulfadiazine12$184
Silver Sulfadiazine11$184
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$60
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$51

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Middletown

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →